MemorialCare Research Center Contact Form
For further information about this study or to express your interest in this study, please fill out and submit this form.
18 years and older
Male or Female
This study will compare the efficacy and safety in of LOXO-305 administered as a continuous monotherapy with Investigator’s choice of standard of care IdelaR or BR. The patient population will have received prior BTK inhibitor therapy as part of any number of prior therapies. Therefore, the patient population is heterogeneous in regards to treatment exposure and future prognosis.